Literature DB >> 21044569

Modeling the effect of Kv1.5 block on the canine action potential.

Joachim Almquist1, Mikael Wallman, Ingemar Jacobson, Mats Jirstrand.   

Abstract

A wide range of ion channels have been considered as potential targets for pharmacological treatment of atrial fibrillation. The Kv1.5 channel, carrying the I(Kur) current, has received special attention because it contributes to repolarization in the atria but is absent or weakly expressed in ventricular tissue. The dog serves as an important animal model for electrophysiological studies of the heart and mathematical models of the canine atrial action potential (CAAP) have been developed to study the interplay between ionic currents. To enable more-realistic studies on the effects of Kv1.5 blockers on the CAAP in silico, two continuous-time Markov models of the guarded receptor type were formulated for Kv1.5 and subsequently inserted into the Ramirez-Nattel-Courtemanche model of the CAAP. The main findings were: 1), time- and state-dependent Markov models of open-channel Kv1.5 block gave significantly different results compared to a time- and state-independent model with a downscaled conductance; 2), the outcome of Kv1.5 block on the macroscopic system variable APD(90) was dependent on the precise mechanism of block; and 3), open-channel block produced a reverse use-dependent prolongation of APD(90). This study suggests that more-complex ion-channel models are a prerequisite for quantitative modeling of drug effects.
Copyright © 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044569      PMCID: PMC2965949          DOI: 10.1016/j.bpj.2010.08.062

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  29 in total

1.  Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.

Authors:  B H Choi; J S Choi; S W Jeong; S J Hahn; S H Yoon; Y H Jo; M S Kim
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

2.  Proarrhythmic and antiarrhythmic actions of ion channel blockers on arrhythmias in the heart: model study.

Authors:  T R Chay
Journal:  Am J Physiol       Date:  1996-07

3.  Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.

Authors:  Karsten Knobloch; Joachim Brendel; Stefan Peukert; Björn Rosenstein; Andreas E Busch; Klaus J Wirth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-05       Impact factor: 3.000

4.  Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1.

Authors:  Yi-mei Du; Xiao-xian Zhang; Dan-na Tu; Ning Zhao; Yan-jie Liu; Hua Xiao; Michael C Sanguinetti; Anruo Zou; Yu-hua Liao
Journal:  J Mol Cell Cardiol       Date:  2010-02-23       Impact factor: 5.000

5.  Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.

Authors:  D J Snyders; S W Yeola
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

6.  Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.

Authors:  David Fedida; Jodene Eldstrom; J Christian Hesketh; Michelle Lamorgese; Laurie Castel; David F Steele; David R Van Wagoner
Journal:  Circ Res       Date:  2003-09-18       Impact factor: 17.367

7.  Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.

Authors:  Erich Wettwer; Ottó Hála; Torsten Christ; Jürgen F Heubach; Dobromir Dobrev; Michael Knaut; András Varró; Ursula Ravens
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

8.  Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.

Authors:  J Snyders; K M Knoth; S L Roberds; M M Tamkun
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

9.  "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.

Authors:  Y Blaauw; H Gögelein; R G Tieleman; A van Hunnik; U Schotten; M A Allessie
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

10.  Shaker potassium channel gating. III: Evaluation of kinetic models for activation.

Authors:  W N Zagotta; T Hoshi; R W Aldrich
Journal:  J Gen Physiol       Date:  1994-02       Impact factor: 4.086

View more
  3 in total

1.  Rate-Dependent Role of IKur in Human Atrial Repolarization and Atrial Fibrillation Maintenance.

Authors:  Martin Aguilar; Jianlin Feng; Edward Vigmond; Philippe Comtois; Stanley Nattel
Journal:  Biophys J       Date:  2017-05-09       Impact factor: 4.033

2.  In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis.

Authors:  Michael A Colman; Haibo Ni; Bo Liang; Nicole Schmitt; Henggui Zhang
Journal:  PLoS Comput Biol       Date:  2017-06-16       Impact factor: 4.475

3.  Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.

Authors:  Haibo Ni; Dominic G Whittaker; Wei Wang; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang
Journal:  Front Physiol       Date:  2017-11-23       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.